Xbiome Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B2

  • Investors
  • 12

Xbiome General Information

Description

Developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals. It uses living biological drugs and microbial small molecule modulators, enabling patients to achieve disease relief or treatment.

Contact Information

Website
xbiome.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 907, 9th Floor, Tsinghua Information Port Research Building
  • Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Room 907, 9th Floor, Tsinghua Information Port Research Building
  • Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xbiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B2) 22-Dec-2021 Completed Clinical Trials - Phase 2
4. Early Stage VC (Series B1) 27-Nov-2020 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 04-Nov-2019 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A1) 01-Jan-2019 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 01-Aug-2018 Completed Clinical Trials - Phase 2
To view Xbiome’s complete valuation and funding history, request access »

Xbiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. The company uses artifici
Biotechnology
Shenzhen, China

Cambridge, MA
 

Hong Kong, Hong Kong
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xbiome Competitors (4)

One of Xbiome’s 4 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
InSilico Medicine Venture Capital-Backed Hong Kong, Hong Kong
Seres Therapeutics Formerly VC-backed Cambridge, MA
Second Genome Formerly VC-backed Brisbane, CA
To view Xbiome’s complete competitors history, request access »

Xbiome Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Xbiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220073996-A1 Model for predicting treatment responsiveness based on intestinal microbial information Pending 22-Jan-2019

Xbiome Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hike Capital Venture Capital Minority
Sky9 Capital Venture Capital Minority
Tiantu Capital Venture Capital Minority
Primavera Venture Partners Venture Capital Minority
Yael Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Xbiome Investments (1)

Xbiome’s most recent deal was a Corporate Asset Purchase with Assembly Biosciences (M201 Program). The deal was made on 25-Apr-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Assembly Biosciences (M201 Program) 25-Apr-2022 Corporate Asset Purchase Buildings and Property
To view Xbiome’s complete investments history, request access »

Ready to get started?

Request a free trial

Xbiome FAQs

  • When was Xbiome founded?

    Xbiome was founded in 2017.

  • Where is Xbiome headquartered?

    Xbiome is headquartered in Shenzhen, China.

  • What industry is Xbiome in?

    Xbiome’s primary industry is Biotechnology.

  • Is Xbiome a private or public company?

    Xbiome is a Private company.

  • What is Xbiome’s current revenue?

    The current revenue for Xbiome is .

  • How much funding has Xbiome raised over time?

    Xbiome has raised $24.1M.

  • Who are Xbiome’s investors?

    Hike Capital, Sky9 Capital, Tiantu Capital, Primavera Venture Partners, and Yael Capital are 5 of 12 investors who have invested in Xbiome.

  • Who are Xbiome’s competitors?

    Vedanta Biosciences, InSilico Medicine, Seres Therapeutics, and Second Genome are competitors of Xbiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »